Sign in Subscribe
Class action lawsuits

Class Action Lawsuit Filed Against Alto Neuroscience, Inc.

Strategic Insights

— 1 min read

Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO) in connection with the company's initial public offering (IPO) conducted on February 2, 2024, and subsequent securities sales between February 2, 2024, and October 22, 2024. Investors who purchased Alto securities during this period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.

Key Takeaways:

  • The class action lawsuit was filed on behalf of investors who purchased Alto common stock in connection with the company's IPO and subsequent securities sales.
  • The lawsuit alleges that Alto's offering documents and public statements made during the Class Period contained false and/or misleading statements regarding the company's business, operations, and prospects.
  • Specific allegations include that Alto's lead product, ALTO-100, was less effective in treating major depressive disorder (MDD) than defendants had led investors to believe.
  • Investors suffered damages when the true details of the company's business and prospects were revealed in the market.
  • The Rosen Law Firm has a track record of success in securities class actions and shareholder derivative litigation, including recovering hundreds of millions of dollars for investors.
  • The firm has been ranked as a leader in securities class action settlements, including being named the top-ranked firm by ISS Securities Class Action Services in 2017.

Statistics:

  • The lawsuit covers the period from February 2, 2024, to October 22, 2024, both dates inclusive.
  • The lead plaintiff must move the Court no later than September 19, 2025, to serve in this capacity.
  • The Rosen Law Firm has secured over $438 million in settlements for investors in 2019 alone, and over $100 million in settlements in 2020.

Sources:

  • "Rosen Law Firm Announces Class Action Lawsuit on Behalf of Purchasers of Common Stock of Alto Neuroscience, Inc." (PPI-PR), February 2025 (exact date not specified).
  • "Rosen Law Firm Announces Class Action Lawsuit on Behalf of Purchasers of Common Stock of Alto Neuroscience, Inc." (https://rosenlegal.com/submit-form/?case_id=42321)
  • "Rosen Law Firm" official website (www.rosenlegal.com).
  • "Law360" article: "Laurence Rosen Named Titan of Plaintiffs' Bar" (2020).
  • "ISS Securities Class Action Services" ranking of Rosen Law Firm as No. 1 in 2017.

Read more